Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Executives On The Move

Set Alert for Executives on The Move

Executives On The Move: Jubilant, Mithra And More

Recent executive moves in the industry include C-suite changes at Jubilant Pharmova and Sanofi. Meanwhile, new directors were appointed at Mithra Pharmaceuticals and Calliditas Therapeutics.

Executive Changes Leadership

Executives On The Move: Oncorus, Orphazyme and More

Recent executive moves in the industry include C-suite changes at Oncorus and Gamida Cell. Meanwhile, new directors were appointed at Orphazyme and Viatris.

Executive Changes Leadership

Executives On The Move: Kintor, Nexus and More

Recent executive moves in the industry include C-suite changes at Kintor Pharmaceutical and Antisense Therapeutics. Meanwhile, new directors were appointed at Nexus Pharmaceuticals and BiomX.

Executive Changes Leadership

Executives On The Move: Grifols, Voyager and More

Recent executive moves in the industry include C-suite changes at Grifols and Zevra Therapeutics. Meanwhile, new directors were appointed at Voyager Therapeutics and Transgene.

Executive Changes Leadership

Executives On The Move: Adagene, Provention and More

Recent executive changes in the industry include C-suite changes at Adagene and AstraZeneca. Meanwhile, new directors were appointed at Provention Bio and WPD Pharmaceuticals.

Executive Changes Leadership

Quick Listen: Scrip's Five Must-Know Things

In this week's podcast edition of Five Must-Know Things: BMS names new CEO; Novartis culls pipeline; AstraZeneca taps Chinese innovation; Q2 approvals to look out for; and a look at deal-making trends in 2022.

Approvals Business Strategies

Executives On The Move: Ocuphire, Vivanza and More

Recent executive moves in the industry include C-suite changes at Ocuphire Pharma and Race Oncology. Meanwhile, new directors were appointed at Vivanza Biosciences and Cue Biopharma.

Executive Changes Leadership

Future BMS CEO Boerner Pleas For Patience As New Products Build Momentum

Christopher Boerner, who will become CEO on 1 November, reported Q1 progress for new drugs Sotyktu, Camzyos and Opdualag, noting that greater growth for these early launches is still to come.

Executive Changes Launches

Executives On The Move: Kintor, Poseida and More

Recent executive moves in the industry include C-suite changes at Kintor Pharmaceutical and BioVaxys Technology. Meanwhile, new directors were appointed Poseida Therapeutics and NeuroNascent. 

Executive Changes Leadership

Quick Listen: Scrip's Five Must-Know Things

In this week's podcast edition of Five Must-Know Things: partial US clinical hold for evobrutinib; Takeda pulls back early AAV gene therapy and rare hematology research; Lilly and Novo shape up for obesity battle; Vir’s new CEO talks to Scrip; and the declining state of pain R&D.

Clinical Trials Commercial

Executives On The Move: Zymeworks, Novan and More

Recent executive moves in the industry include C-suite changes at NervGen Pharma and Novan. Meanwhile, new directors were appointed at Zymeworks and Mirum Pharmaceuticals.

Executive Changes Leadership

Executives On The Move: Heron Therapeutics, Achieve Life Sciences and More

Recent executive changes in the industry include C-suite changes at Inozyme Pharma and Heron Therapeutics. Meanwhile, new directors were appointed Achieve Life Sciences and Entrada Therapeutics.

Executive Changes Leadership
See All
UsernamePublicRestriction

Register